Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer

BJU International

Volumn 106, Issue 11, 2010, Pages 1739-1745

  Wambi, Chris O ^a   Siddiqui, Sameer A ^a   Krane, L Spencer ^a   Agarwal, Piyush K ^a   Stricker, Hans J ^a   Peabody, James O ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

cancer; Gleason; high grade; prostate; robotics; tumour volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED SURGERY; FOLLOW UP; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; ROBOT ASSISTED RADICAL PROSTATECTOMY; ROBOTICS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME; UNIVARIATE ANALYSIS;

AGED; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROBOTICS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 78649293511     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09484.x     Document Type: Article

References (35)

1. Badani KK, Kaul S, Menon M,. Evolution of robotic radical prostatectomy: assessment after 2766 procedures. Cancer 2007; 110: 1951 - 8
2. Rassweiler J, Hruza M, Teber D, Su LM,. Laparoscopic and robotic assisted radical prostatectomy - critical analysis of the results. Eur Urol 2006; 49: 612 - 24
3. Schroeck FR, Sun L, Freedland SJ, et al. Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy. BJU Int 2008; 102: 28 - 32
4. Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL,. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435 - 48
5. Albertsen PC, Hanley JA, Fine J,. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293: 2095 - 101
6. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330: 242 - 8
7. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH,. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003; 21: 2163 - 72
8. Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005; 294: 433 - 9
9. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC,. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591 - 7
10. Donohue JF, Bianco FJ Jr, Kuroiwa K, et al. Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. J Urol 2006; 176: 991 - 5
11. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H,. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol 2002; 167: 117 - 22
12. Mian BM, Troncoso P, Okihara K, et al. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol 2002; 167: 1675 - 80
13. Farkas A, Schneider D, Perrotti M, Cummings KB, Ward WS,. National trends in the epidemiology of prostate cancer, 1973-94: evidence for the effectiveness of prostate-specific antigen screening. Urology 1998; 52: 444 - 9
14. Kane CJ, Presti JC Jr, Amling CL, Aronson WJ, Terris MK, Freedland SJ,. Changing nature of high risk patients undergoing radical prostatectomy. J Urol 2007; 177: 113 - 7
15. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M,. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004; 172: 508 - 11
16. Van Poppel H, Joniau S,. An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer. Eur Urol 2008; 53: 253 - 9
17. Menon M, Tewari A, Peabody J, VIP Team. Vattikuti Institute prostatectomy: technique. J Urol 2003; 169: 2289 - 92
18. Carvalhal GF, Humphrey PA, Thorson P, Yan Y, Ramos CG, Catalona WJ,. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer 2000; 89: 1308 - 14
19. Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007; 177: 540 - 5
20. Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML,. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers. BJU Int 2008; 101: 299 - 304
21. Cheng L, Koch MO, Juliar BE, et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol 2005; 23: 2911 - 7
22. Chun FK, Briganti A, Jeldres C, et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 2007; 43: 536 - 43
23. Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ,. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 2004; 172: 137 - 40
24. Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ,. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. J Urol 2008; 180: 571 - 6
25. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM,. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395 - 400
26. Nelson BA, Shappell SB, Chang SS, et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006; 97: 1169 - 72
27. Epstein JI, Carmichael M, Partin AW, Walsh PC,. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149: 1478 - 81
28. Salomon L, Levrel O, Anastasiadis AG, et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol 2003; 43: 39 - 44
29. Merrill MM, Lane BR, Reuther AM, Zhou M, Magi-Galluzzi C, Klein EA,. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 2007; 70: 294 - 8
30. Yossepowitch O, Eggener SE, Bianco FJ Jr, et al. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. J Urol 2007; 178: 493 - 9
31. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969 - 74
32. Bastian PJ, Gonzalgo ML, Aronson WJ, et al. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer 2006; 107: 1265 - 72
33. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977 - 84
34. Merglen A, Schmidlin F, Fioretta G, et al. Short- and long-term mortality with localized prostate cancer. Arch Intern Med 2007; 167: 1944 - 50
35. Tewari A, Divine G, Chang P, et al. Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy - a propensity scoring approach. J Urol 2007; 177: 911 - 5